Patents by Inventor Hyoweon Bang

Hyoweon Bang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient
    Patent number: 8012486
    Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutenone as an active ingredient. Hirsutenone as the active ingredient of the present composition decreases the number of eosinophil and the level of IgE increased in atopic dermatitis and remarkably reduces expression amounts of immune regulatory cytokine (e.g., IL-4, IL-5 and IL-13) associated with atopic dermatitis. In addition, hirsutenone decreases COX-2 and iNOS expression. Hirsutenone as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis or relieving a symptom of atopic dermatitis.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 6, 2011
    Assignee: Chung-Ang University Industry Academic Cooperation Foundation
    Inventors: Min Won Lee, Young Wook Choi, Seong Jun Seo, Do Ik Lee, Hyoweon Bang, Chung Soo Lee, Jong Chan Lee, Soon-Chul Myung, Mi-Kyung Lee, Seong Soo Joo, Sun Eun Choi
  • Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient
    Publication number: 20100190729
    Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutanonol as an active ingredient. Hirsutanonol or oregonin as the active ingredient of the present composition decreases the number of eosinophil increased in atopic dermatitis and regulates expression amounts of immune regulatory cytokines, IL-4, IL-5, IL-10 and IL-13 associated with atopic dermatitis. In addition, hirsutanonol and oregonin increase MBD (mouse beta-defensin)-1, MBD-2 and MBD-3 expression and decrease COX-2 and iNOS expression in mouse animal model of atopic dermatitis. Hirsutanonol and oregonin as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis.
    Type: Application
    Filed: May 19, 2009
    Publication date: July 29, 2010
    Applicant: CHUNG-ANG University Industry Academic Cooperation Foundation
    Inventors: Min Won Lee, Young Wook Choi, Seong Jun Seo, Do Ik Lee, Hyoweon Bang, Chung Soo Lee, Jong Chan Lee, Soon-Chul Myung, Mi-Kyung Lee, Seong Soo Joo, Sun Eun Choi
  • Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient
    Publication number: 20100190862
    Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutenone as an active ingredient. Hirsutenone as the active ingredient of the present composition decreases the number of eosinophil and the level of IgE increased in atopic dermatitis and remarkably reduces expression amounts of immune regulatory cytokine (e.g., IL-4, IL-5 and IL-13) associated with atopic dermatitis. In addition, hirsutenone decreases COX-2 and iNOS expression. Hirsutenone as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis or relieving a symptom of atopic dermatitis.
    Type: Application
    Filed: May 19, 2009
    Publication date: July 29, 2010
    Applicant: CHUNG-ANG University Industry Academic Cooperation Foundation
    Inventors: Min Won Lee, Young Wook Choi, Seong Jun Seo, Do Ik Lee, Hyoweon Bang, Chung Soo Lee, Jong Chan Lee, Soon-Chul Myung, Mi-Kyung Lee, Seong Soo Joo, Sun Eun Choi